Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease

Therapeutic Advances in Gastroenterology

Volumn 4, Issue 3, 2011, Pages 169-176

  Touzin, Nadege T ^a   Bush, Kelvin N v ^a   Harrison, Stephen A ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Colonic adenomas; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLON ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STEATOSIS;

EID: 80052308377     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X11402118     Document Type: Article

References (30)

1. Ahmed R.L. Shmitz K.H. Anderson K.E. Rosamond W.D. Folsom A.R. (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107: 28–36.
2. Boyle P. Leon M.E. (2002) Epidemiology of colorectal cancer. Br Med Bull 64: 1–25.
3. Brunt E.M. Janney C.G. Di Bisceglie A.M. Neuschwander-Tetri B.A. Bacon B.R. (1999) Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467–2474.
4. Colangelo L.A. Gapstur S.M. Gann P.H. Dyer A.R. Liu K. (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11: 385–391.
5. Cowey S. Hardy R. (2006) Metabolic syndrome, a high risk state for cancer? Am J Pathol 169: 1505–1522.
6. Ferroni P. Palmirotta R. Spila A. Martini F. Raparelli V. Fossile E. et al (2007) Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 27: 483–489.
7. Giovannucci E. (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr 86: s836–s842.
8. Grimberg A. Cohen P. (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1–9.
9. Hwang S.T. Cho Y.K. Park J.H. (2010) Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 25: 562–567.
10. Kaaks R. Toniolo P. Akhmedkhanov A. (2000) Serum C-peptide, insulin growth factor (IGF-1), IGF-binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592–1600.
11. Kim J.H. Lim Y.J. Kim Y.H. (2007) Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 16: 1543–1546.
12. Labianca R. Beretta G.D. Kildani B. (2010) Colon cancer. Crit Rev Oncol Hematol 74: 106–133.
13. Larsson S.C. Wolk A. (2007) Obesity and colon and rectal cancer risk: A meta-analysis of prospective studies. Am J Clin Nutr 86: 556–565.
14. Liu C.S. Hsu H.S. Li C.I. (2010) Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol 10: 51–51.
15. Nelson R.S. Thorson A.G. (2009) Colorectal cancer screening. Curr Oncol Rep 1: 482–489.
16. Pais R. Silaghi H. Silaghi A.C. Rusu M.L. Dumitrascu D.L. (2009) Metabolic syndrome and the risk of subsequent colorectal cancer. World J Gastroenterol 15: 5141–5148.
17. Patel A.A. Torres D.M. Harrison S.A. (2009) Effect of weight loss on nonalcoholic fatty liver disease. J Clin Gastroenterol 43: 970–974.
18. Pittas A.G. Joseph N.A. Greenberg A.S. (2004) Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89: 447–452.
19. Powell E.E. Jonsson C.R. Clouston A.D. Powell E.E. Jonsson J.R. Clouston A.D. (2005) Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med 143: 753–754.
20. Reilly M.P. Rader D.J. (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108: 1546–1551.
21. Rex D.K. Johnson D.A. Anderson J.C. (2009) American College of Gastroenterology guidelines on colorectal screening. Am J Gastroenterol 104: 739–750.
22. Rose D.P. Komninou D. Stephenson G.D. (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5: 153–165.
23. Rubinstein E. Lavine J.E. Schwimmer J.B. (2008) Hepatic, cardiovascular, and endocrine outcomes of the histologic subphenotype of nonalcoholic fatty liver disease. Sem Liv Dis 28: 380–385.
24. Shoelson S.E. Lee J. Goldfine A.B. (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793–1801.
25. Sonnenberg G.E. Krakower G.R. Kissebah A.H. (2004) A novel pathway to the manifestations of metabolic syndrome. Obes Res 12: 180–186.
26. Stattin P. Lukanova A. Biessy C. (2004) Obesity and colon cancer: Does leptin provide a link? Int J Cancer 109: 149–152.
27. Trayhurn P. Wood I.S. (2004) Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347–355.
28. Trevisan M. Liu J. Muti P. Misciagna G. Menottim A. Fucci F. et al. (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10: 937–941.
29. Warren R.S. Yuan H. Matli M.R. Ferrara N. Donner D.B. (1996) Induction of vascular endothelial growth factor by insulin growth factor 1 in colorectal carcinoma. J Biol Chem 271: 29483–29488.
30. Williams C.D. Stengel J. Asike M.I. Torres D.M. Shaw J. Contreras M. et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 140: 124–131.